ST
Sevenless Therapeutics
InactiveThe startup is developing small molecule therapeutics targeting pain pathways to provide effective relief for chronic pain conditions. Their approach focuses on enhancing analgesic efficacy while minimizing side effects associated with current pain management options.
- Biotechnology
Updated 5 months ago
Funding
Raised to date
$1.3MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup is developing small molecule therapeutics targeting pain pathways to provide effective relief for chronic pain conditions. Their approach focuses on enhancing analgesic efficacy while minimizing side effects associated with current pain management options.